Daxor Gross Profit 2010-2011 | DXR

Daxor gross profit from 2010 to 2011. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Daxor Annual Gross Profit
(Millions of US $)
2011 $1
2010 $1
2009 $1
Daxor Quarterly Gross Profit
(Millions of US $)
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.759B 16.29
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Chemed (CHE) United States $8.450B 26.19
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
Amedisys (AMED) United States $3.162B 22.40
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00